Evidence check: CYP2D6 in the context of longevity

The provided context does not contain any direct evidence linking CYP2D6 to longevity. CYP2D6 is a well-known drug-metabolizing enzyme, and some research has explored its variants in relation to age-related diseases or response to supplements, but the evidence is weak and inconsistent. The context covers topics like APOE, FUT2, microbiome, and diet, but not CYP2D6. Therefore, any claim about CYP2D6 and longevity is not supported by the given information. Users should be cautious: consumer genetic tests often report CYP2D6 variants for medication guidance, but their role in extending lifespan is speculative at best. A conservative assessment rates the evidence as unclear. For personalized advice, consult a healthcare professional familiar with pharmacogenetics.